Zhuhai Cariad Medical Technology Co., Ltd.

Zhuhai Cariad Medical Technology Co., Ltd. specializes in diagnostic reagents and equipment designed for sperm analysis. Their products include staining solutions for evaluating sperm morphology, vitality, and DNA fragmentation—such as Diff-Quik, Acridine Orange, and Sperm Chromatin Dispersion methods—along with automated staining machines. These tools are primarily used in reproductive health diagnostics to assess sperm quality and fertility potential.

The company is headquartered in Zhuhai, China. This location allows it to leverage regional expertise in reproductive health diagnostics while adhering to global regulatory standards. Since its devices are Class A medical devices, they typically pose minimal risk, enabling streamlined compliance processes. The company’s focus on advanced diagnostic solutions aligns with China’s growing demand for reproductive health technologies.

Yes, the company’s devices are listed in the eudamed registry, which is the European Union’s central database for medical devices. This inclusion ensures transparency regarding their presence in the EU market, though listing alone does not imply regulatory approval—individual devices must undergo their own conformity assessment processes to meet EU requirements.

All of Zhuhai Cariad’s devices fall under Class A classification, which is the lowest risk category in medical device regulations. This classification applies because their products—such as staining solutions and automated staining machines—are intended for diagnostic purposes with minimal risk to patients, typically involving in vitro tests rather than invasive procedures or high-risk interventions.